Arena Pharmaceuticals ARNA

$ 49.55 -6.81%

Annual report 2021
added 12-16-2023

Arena Pharmaceuticals Balance Sheet 2011-2024 | ARNA

Annual Balance Sheet Arena Pharmaceuticals

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-25.4 M	-87.9 M	-92.5 M	-149 M	-81.6 M	32.8 M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	14.7 M
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	52.2 M	57.7 M	50.7 M	59.8 M	64.7 M	153 M	162 M	177 M	133 M	132 M
Total Current Liabilities	66.3 M	58.1 M	45 M	29.9 M	72.3 M	63.9 M	49.9 M	67.4 M	70.7 M	29.9 M	14.4 M
Total Liabilities	-	110 M	103 M	80.6 M	132 M	129 M	203 M	229 M	248 M	163 M	147 M
Deferred Revenue	-	-	-	-	1.11 M	35.3 M	21.4 M	15.2 M	37.9 M	15.5 M	3.47 M
Retained Earnings	-2.12 B	-1.51 B	-1.1 B	-1.5 B	-1.49 B	-1.4 B	-1.38 B	-1.27 B	-1.21 B	-1.19 B	-1.08 B
Total Assets	785 M	1.19 B	1.17 B	687 M	339 M	169 M	257 M	276 M	340 M	261 M	157 M
Cash and Cash Equivalents	-	220 M	243 M	161 M	159 M	90.7 M	156 M	163 M	222 M	156 M	57.6 M
Book Value	785 M	1.08 B	1.07 B	606 M	207 M	40.4 M	53.5 M	47.3 M	91.9 M	98.6 M	10.6 M
Total Shareholders Equity	673 M	1.08 B	1.07 B	606 M	207 M	39.9 M	53.5 M	47.3 M	91.9 M	98.6 M	10.6 M

All numbers in USD currency

Quarterly Balance Sheet Arena Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	8.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	800 K	800 K	800 K	1.11 M	1.11 M	1.11 M	1.11 M	4.41 M	35.3 M	35.3 M	35.3 M	21.4 M	21.4 M	21.4 M	21.4 M	15.2 M	15.2 M	15.2 M	15.2 M	37.9 M	37.9 M	37.9 M	37.9 M	15.5 M	15.5 M	15.5 M	15.5 M	3.47 M	3.47 M	3.47 M	3.47 M
Retained Earnings	-	-	-	-	-2.12 B	-1.97 B	-1.77 B	-1.63 B	-1.51 B	-1.51 B	-1.51 B	-1.2 B	-1.1 B	-1.1 B	-1.1 B	-1.1 B	-1.5 B	-1.5 B	-1.5 B	-1.5 B	-1.49 B	-1.49 B	-1.49 B	-1.49 B	-1.4 B	-1.4 B	-1.4 B	-1.4 B	-1.38 B	-1.38 B	-1.38 B	-1.38 B	-1.27 B	-1.27 B	-1.27 B	-1.27 B	-1.21 B	-1.21 B	-1.21 B	-1.21 B	-1.19 B	-1.19 B	-1.19 B	-1.19 B	-1.08 B	-1.08 B	-1.08 B	-1.08 B
Total Assets	-	-	-	-	785 M	901 M	1.08 B	1.18 B	1.19 B	1.19 B	1.19 B	1.09 B	1.17 B	1.17 B	1.17 B	1.17 B	687 M	687 M	687 M	687 M	339 M	339 M	339 M	339 M	169 M	169 M	169 M	169 M	257 M	257 M	257 M	257 M	276 M	276 M	276 M	276 M	340 M	340 M	340 M	340 M	261 M	261 M	261 M	261 M	157 M	157 M	157 M	157 M
Cash and Cash Equivalents	-	-	-	-	225 M	387 M	514 M	433 M	220 M	220 M	220 M	220 M	243 M	243 M	243 M	243 M	161 M	161 M	161 M	161 M	159 M	159 M	159 M	159 M	90.7 M	90.7 M	90.7 M	90.7 M	156 M	156 M	156 M	156 M	163 M	163 M	163 M	163 M	222 M	222 M	222 M	222 M	156 M	156 M	156 M	156 M	57.6 M	57.6 M	57.6 M	57.6 M
Book Value	-	-	-	-	785 M	901 M	1.08 B	1.18 B	1.19 B	1.19 B	1.19 B	1.09 B	1.17 B	1.17 B	1.17 B	1.17 B	687 M	687 M	687 M	687 M	339 M	339 M	339 M	339 M	169 M	169 M	169 M	169 M	257 M	257 M	257 M	257 M	276 M	276 M	276 M	276 M	340 M	340 M	340 M	340 M	261 M	261 M	261 M	261 M	157 M	157 M	157 M	157 M
Total Shareholders Equity	-	-	-	-	673 M	801 M	971 M	1.09 B	1.08 B	1.17 B	1.08 B	1.08 B	1.07 B	1.15 B	1.07 B	1.07 B	606 M	606 M	606 M	606 M	207 M	207 M	207 M	207 M	39.9 M	39.9 M	39.9 M	39.9 M	53.5 M	53.5 M	53.5 M	53.5 M	47.3 M	47.3 M	47.3 M	47.3 M	91.9 M	91.9 M	91.9 M	91.9 M	98.6 M	98.6 M	98.6 M	98.6 M	10.6 M	10.6 M	10.6 M	10.6 M

All numbers in USD currency